Literature DB >> 11032757

Downregulation of cyclin D1 alters cdk 4- and cdk 2-specific phosphorylation of retinoblastoma protein.

B Yu1, M E Lane, R G Pestell, C Albanese, S Wadler.   

Abstract

Progression of cells through the G1 phase of the cell cycle requires the assembly and activation of specific cyclin:cyclin-dependent kinase (cdk) complexes in a tightly regulated, sequential fashion. To more clearly define the temporal events leading to the G1/S transition, sequential changes in the expression of cyclin E and cdks 2, 4, and 6, as well as the phosphorylation of the retinoblastoma protein (pRb), were assayed in RA28 cells, a variant of human colon cancer RKO cells which were modified by transfection of an ecdysone-inducible antisense (AS) CD1 expression system. Induction of cyclin D1 antisense mRNA by the ecdysteroid, ponasterone A, resulted in a 55% decrease in cyclin D1 mRNA and a 58% decrease in CD1 protein levels. There was a 2.4-fold decrease in the ratio of hyperphosphorylated pRb (ppRb) to hypophosphorylated pRb, as well as a 60-75% decrease in cdk 2- and cdk 4-specific phosphorylated pRb proteins. Of interest, cyclin E-dependent phosphorylation (cdk2) decreased 2.5-fold at 3 h despite only a 30% decrease in cyclin E protein level. Levels of cdk 2, cdk 4, and cdk 6 decreased 40-70%, while levels of cyclin A and B were unaffected by induction of CD1 antisense. Induction of a CD1 antisense gene in a human colon cancer cell line resulted in rapid, concomitant changes in CD1 mRNA and protein, cyclin E, cdk2, cdk4, and cdk6, as well as the ratio of ppRb to pRb. In this system, growth regulatory events are tightly regulated and the perturbed expression of a single protein, CD1, rapidly alters expression of multiple regulatory proteins involved in the G1/S transition phase of cell cycle progression. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11032757     DOI: 10.1006/mcbr.2000.0238

Source DB:  PubMed          Journal:  Mol Cell Biol Res Commun        ISSN: 1522-4724


  15 in total

1.  Molecular mechanism of inhibitory effects of C-phycocyanin combined with all-trans-retinoic acid on the growth of HeLa cells in vitro.

Authors:  Fan Yang; Bing Li; Xian-Ming Chu; Cong-Yi Lv; Ying-Jie Xu; Peng Yang
Journal:  Tumour Biol       Date:  2014-02-23

2.  Colonic organoids derived from human induced pluripotent stem cells for modeling colorectal cancer and drug testing.

Authors:  Miguel Crespo; Eduardo Vilar; Su-Yi Tsai; Kyle Chang; Sadaf Amin; Tara Srinivasan; Tuo Zhang; Nina H Pipalia; Huanhuan Joyce Chen; Mavee Witherspoon; Miriam Gordillo; Jenny Zhaoying Xiang; Frederick R Maxfield; Steven Lipkin; Todd Evans; Shuibing Chen
Journal:  Nat Med       Date:  2017-06-19       Impact factor: 53.440

3.  The CDK4/6 inhibitor PD0332991 reverses epithelial dysplasia associated with abnormal activation of the cyclin-CDK-Rb pathway.

Authors:  M Carla Cabrera; Edgar S Díaz-Cruz; Bhaskar V S Kallakury; Michael J Pishvaian; Clinton J Grubbs; Donald D Muccio; Priscilla A Furth
Journal:  Cancer Prev Res (Phila)       Date:  2012-04-16

4.  Curcumin (diferuloylmethane) inhibits cell proliferation, induces apoptosis, and decreases hormone levels and secretion in pituitary tumor cells.

Authors:  Matthew Miller; Shenglin Chen; Jeffrey Woodliff; Sanjay Kansra
Journal:  Endocrinology       Date:  2008-05-01       Impact factor: 4.736

5.  Prolonged Partial Response to Bevacizumab and Valproic Acid in a Patient With Glioblastoma.

Authors:  Elena Fountzilas; Gary Palmer; David Vining; Apostolia-Maria Tsimberidou
Journal:  JCO Precis Oncol       Date:  2018-12-21

6.  Cyclin D1 repression of peroxisome proliferator-activated receptor gamma expression and transactivation.

Authors:  Chenguang Wang; Nagarajan Pattabiraman; Jian Nian Zhou; Maofu Fu; Toshiyuki Sakamaki; Chris Albanese; Zhiping Li; Kongming Wu; James Hulit; Peter Neumeister; Phyllis M Novikoff; Michael Brownlee; Philipp E Scherer; Joan G Jones; Kathleen D Whitney; Lawrence A Donehower; Emily L Harris; Thomas Rohan; David C Johns; Richard G Pestell
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

7.  Antisense-mediated loss of calcium homoeostasis endoplasmic reticulum protein (CHERP; ERPROT213-21) impairs Ca2+ mobilization, nuclear factor of activated T-cells (NFAT) activation and cell proliferation in Jurkat T-lymphocytes.

Authors:  Flavia A O'Rourke; Janice M LaPlante; Maurice B Feinstein
Journal:  Biochem J       Date:  2003-07-01       Impact factor: 3.857

8.  Cyclin D1 and Rb protein expression and their correlation with prognosis in patients with colon cancer.

Authors:  Gregory Kouraklis; Stamos Theocharis; Panayiotis Vamvakas; Costas Vagianos; Andromahi Glinavou; Costas Giaginis; Crysoula Sioka
Journal:  World J Surg Oncol       Date:  2006-01-20       Impact factor: 2.754

9.  Deterministic Effects Propagation Networks for reconstructing protein signaling networks from multiple interventions.

Authors:  Holger Fröhlich; Ozgür Sahin; Dorit Arlt; Christian Bender; Tim Beissbarth
Journal:  BMC Bioinformatics       Date:  2009-10-08       Impact factor: 3.169

10.  Net1 and Myeov: computationally identified mediators of gastric cancer.

Authors:  J Leyden; D Murray; A Moss; M Arumuguma; E Doyle; G McEntee; C O'Keane; P Doran; P MacMathuna
Journal:  Br J Cancer       Date:  2006-04-24       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.